Beam stock forecast.

18/10/2023. IBA plans total system restoration on its first-ever proton therapy installation. Analytical report. Stock ION BEAM APPLICATIONS Common Stock BE0003766806 XBRU Euronext Brussels Live Euronext quotes, realtime prices, charts and regulated news.

Beam stock forecast. Things To Know About Beam stock forecast.

Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60. The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46. Stock Price Forecast. The 20 analysts offering 12-month price forecasts for Nintendo Co Ltd have a median target of 46.72, with a high estimate of 59.00 and a low estimate of 31.78. The median ...According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest …11 brokers have issued 12 month price objectives for Beam Therapeutics' stock. Their BEAM share price targets range from $20.00 to $105.00. On average, they …

14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Beam Therapeutics Inc. (BEAM) NasdaqGS - NasdaqGS Real Time Price....TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comAccording to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest target is $32 and the highest is $105. On average, analysts rate BEAM stock stock as a buy. Analyst Consensus: Buy * Price targets were last updated on Oct 17, 2023. Analyst Ratings

Nov 30, 2023 · Beam Therapeutics Inc. (BEAM) Stock Price, Quote & News - Stock Analysis 29.67 +0.20 (0.68%) At close: Nov 24, 2023, 1:00 PM 30.22 +0.55 (1.85%) After-hours: Nov 24, 2023, 4:42 PM EST Overview Financials Statistics Profile Chart 1Y Max 0.68% ( 1D) About BEAM

EXAS Stock 12 Months Forecast. $95.46. (50.43% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Exact Sciences in the last 3 months. The average price target is $95.46 with a high forecast of $120.00 and a low forecast of $80.00. The average price target represents a 50.43% change from the last price of $63.46.INFIBEAM INFIBEAM:- wait till breakout keep an eye on the stock Hello traders, As always, simple and neat charts so everyone can understand and not make it too complicated. rest details mentioned in the chart. will be posting more such ideas like this. Until that, like share and follow :) check my othe INFIBEAM:- wait till breakout keep an eye on the stock Hello …Find real-time NOK - Nokia Oyj stock quotes, company profile, news and forecasts from CNN Business.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

The Beam Therapeutics stock forecast for tomorrow is $ 27.79, which would represent a -6.02% loss compared to the current price. In the next week, the price of BEAM is expected to decrease by -2.93% and hit $ 28.70. As far as the long-term Beam Therapeutics stock forecast is concerned, here’s what our predictions are currently suggesting.

The Beam Therapeutics Inc. stock price gained 5.44% on the last trading day (Wednesday, 22nd Nov 2023), rising from $27.95 to $29.47. During the last trading day the stock fluctuated 5.68% from a day low at $28.24 to a day high of $29.84. The price has been going up and down for this period, and there has been a 28.69% gain for the last 2 weeks.

People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Aug 13, 2023 · The Vanguard Group, Inc. is the second largest shareholder owning 8.3% of common stock, and Arch Venture Partners, L.P. holds about 7.1% of the company stock. Furthermore, CEO John Evans is the ... Second, Amgen is forecast to post a respectable 4.1% rise in annual sales in 2022. ... A deeply undervalued gene-editing stock. Beam Therapeutics (BEAM 0.68%) ...Price target. 49.67 0.00 0.00%. The 12 analysts offering 1 year price forecasts for BEAM have a max estimate of — and a min estimate of —.See Beam Therapeutics Inc. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

October 30, 2023 at 7:00 AM · 5 min read. Wall Street expects a year-over-year increase in earnings on lower revenues when Beam Therapeutics Inc. (BEAM) reports results for the quarter ended ...The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46. Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Beam Therapeutics (BEAM) Stock Price, News & Analysis $29.47 +1.52 (+5.44%) (As of 05:07 PM ET) Compare Today's Range $28.28 $29.84 50-Day Range $17.69 $30.76 52-Week Range $16.95 $51.60 Volume 1.35 million shs Average Volume 986,767 shs Market Capitalization $2.40 billion P/E Ratio N/A Dividend Yield N/A Price Target $48.80

Average 51.83 75.87% Upside Low 19.00 -35.53% Downside High 95.00 222.36% Upside Broker Rating Beam Therapeutics Inc. currently has an average brokerage recommendation (ABR) of 1.86 on a scale of... Beam Therapeutics Stock Forecast Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 0.2% based on the past 3 years of stock performance. Beam Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Accel partner Amy Saper, who is also a former Stripe employee, led the financing for the five-month-old startup. Beam, a five-month-old startup out to more easily help general contractors pay subcontractors and get paid themselves, has rais...The average stock forecast for Beam Therapeutics Inc (BEAM) is 54.77 USD. This price target corresponds to an upside of 85.21%. The range of stock …Nov 18, 2023 · Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years. Beam Therapeutics ( BEAM 0.68%) recently signed a major research deal with Pfizer ( PFE 0.59%) that could be worth up to $1.35 billion, and hardly anyone seemed to notice. This was clearly great ...The first Wood-backed stock we’ll look at is Beam Therapeutics, ... Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast)According to our current BEAM stock forecast, the value of Beam Therapeutics shares will drop by -2.93% and reach $ 28.70 per share by December 8, …Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...Drug-developer Vaxart ( VXRT -1.13%) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Beam Global share forecasts, stock quote and buy / sell signals below. According to present data Beam Global's BEEM shares and potentially its market environment have been in bearish cycle last 12 months (if exists). (See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...

Most industries use structural steel beams to build their structures due to their strength, ease of construction and durability. The cost of structural steel beams varies depending on their size and shape.

According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00.

Jun 13, 2022 - Beam Therapeutics stock forecast & analyst price target predictions based on 9 analysts offering 12-months price targets for BEAM in the last 3 months. Pinterest. Today. Watch. Shop. Explore. When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with ...In the field of construction, the use of steel beams is vital for providing structural support and stability to buildings. When it comes to steel beams, using standardized sizes has numerous benefits.Oct 20, 2023 · According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $53.64 with a high price target of $105.00 and a low price target of $20.00. January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest …Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.INFIBEAM INFIBEAM:- wait till breakout keep an eye on the stock Hello traders, As always, simple and neat charts so everyone can understand and not make it too complicated. rest details mentioned in the chart. will be posting more such ideas like this. Until that, like share and follow :) check my othe INFIBEAM:- wait till breakout keep an eye on the stock Hello …Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Schrodinger Inc have a median target of 47.00, with a high estimate of 80.00 and a low estimate of 29.00. The median ...See the latest Beam Global stock price (BEEM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...

Find real-time BMRN - Biomarin Pharmaceutical Inc stock quotes, company profile, news and forecasts from CNN Business.View the real-time BEAM price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, ...BEKE one year forecast. KE Holdings stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast BEKE stock forecast for 2023 – 2027. Last updated: October 26, 2023. Are you interested in KE Holdings Inc. stocks prediction? ... BEAM Stock Forecast; BE Stock Forecast;Instagram:https://instagram. best fixed rate annuitiestd ameritrade paper trading optionssimens stocksimulation trading stocks Find the latest Olema Pharmaceuticals, Inc. (OLMA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ... best world stock etfreviews for mutual of omaha medicare supplement Jun 13, 2022 - Beam Therapeutics stock forecast & analyst price target predictions based on 9 analysts offering 12-months price targets for BEAM in the last 3 months. Pinterest. Today. Watch. Shop. Explore. When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with ...Nov 29, 2023 · See the latest Beam Global stock price (BEEM:XNAS), related news, valuation, dividends and more to help you make your investing decisions. invesco db us dollar index bullish fund 18/10/2023. IBA plans total system restoration on its first-ever proton therapy installation. Analytical report. Stock ION BEAM APPLICATIONS Common Stock BE0003766806 XBRU Euronext Brussels Live Euronext quotes, realtime prices, charts and regulated news.NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.